Table 4 Median OS, HR and 95%CIs between intervention and contrast group
Authors (year) | Combination group (95% CI)/months | TACE alone group (95% CI)/months | HR (95% CI) |
|---|---|---|---|
Kudo et al. (2011) [15] | 29.7 (28.6-NA) | NA | 1.06 (0.69–1.64) |
Lencioni et al. (2012) [10] | NA | NA | 0.898 (0.606–1.33) |
Qu et al. (2012) [45] | 27 (21.9–32.1) | 17 (8.9–25.0) | NA |
Bai et al. (2013) [46] | 7.5 | 5.1 | 0.61 (0.423–0.884) |
Muhammad et al. (2013) [47] | 20.6 (13.4–38.4) | 18.3 (11.8–32.9) | 0.82 (0.38–1.77) |
Hu et al. (2014) [14] | 7.0 | 4.9 | 0.63 (0.48–0.84) |
Ohki et al. (2015) [6] | 28.7 | 15.6 | 0.43 (0.24–0.76) |
Yao et al. (2015) [12] | 21.7 | 11.5 | 0.449 (0.302–0.668) |
Wan et al.(2016) [50] | 20.23 | 13.97 | 0.75 (0.61–0.94) |
Zhang et al. (2016) [49] | 14.9 (6.8–23.0) | 6.1 (4.0–8.1) | NA |
Varghese et al. (2017) [13] | BCLC-B = 16 (12.9–19.1) | BCLC-B = 9 (6.3–11.7) | BCLC-B:NA |
BCLC-C = 9 (6.8–11.2) | BCLC-C = 4(3–5) | BCLC-C:NA |